Krka, d. d., Novo mesto declares that its active substance valsartan is not supplied by the manufacturer Zhejiang Huahai Pharmaceutical Co. Ltd, China, and that our medicinal products do not contain active substance valsartan from this manufacturer.

Additionally, laboratory analyses have confirmed again that the finished products of valsartan from Krka, d. d., Novo mesto, do not contain N-nitrosodimethylamine (NDMA) and as such do not present any potential health risk to users of our products. Krka’s valsartan medicines remain available on all markets without any restrictions.